Bianchini, D., Omlin, A., Pezaro, C., Lorente, D., Ferraldeschi, R., Mukherji, D., . . . Danila, D. C. (2013). First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. Nature Publishing Group.
Styl ChicagoBianchini, D., et al. First-in-human Phase I Study of EZN-4176, a Locked Nucleic Acid Antisense Oligonucleotide to Exon 4 of the Androgen Receptor MRNA in Patients With Castration-resistant Prostate Cancer. Nature Publishing Group, 2013.
Citace podle MLABianchini, D., et al. First-in-human Phase I Study of EZN-4176, a Locked Nucleic Acid Antisense Oligonucleotide to Exon 4 of the Androgen Receptor MRNA in Patients With Castration-resistant Prostate Cancer. Nature Publishing Group, 2013.